Public reporting burden for this collection of information is estimated to average 1 hour per response, including tha time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and to the Office of Management and Budget, Paperwork Reduction Project (07040188), Washington, DC 20503.
AGENCY USE ONLY (Leave blank}2. REPORT DATE October 1998
REPORT TYPE AND DATES COVERED
Final (20 Sep 93-19 Sep 98)
TITLE AND SUBTITLENeural Responses to Injury: Prevention, Protection, and
FUNDING NUMBERS
DAMD17-93-V-3013
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES)Louisiana
FOREWORDOpinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army.( ) Where copyrighted material is quoted, permission has been obtained to use such material.( ) Where material from documents designated for limited distribution is quoted, permission has been obtained to use the material.( ) Citations of commercial organizations and trade names in this report do not constitute an official Department of Army endorsement or approval of the products or services of these organizations.(v/) In conducting research using animals, the investigator(s) adhered to the "Guide for the Care and Use of Laboratory Animals," prepared by the Committee on Care and use of Laboratory Animals of the Institute of Laboratory Resources, National Research Council (NIH Publication No. 86-23, Revised 1985).(S) For the protection of human subjects, the investigator(s) adhered to policies of applicable Federal Law 45 CFR 46.( ) In conducting research utilizing recombinant DNA technology, the investigator(s) adhered to current guidelines promulgated by the National Institutes of Health.( ) In the conduct of research utilizing recombinant DNA, the investigator(s) adhered to the NIH guidelines for Research Involving Recombinant DNA Molecules.( ) In the conduct of research involving hazardous organisms, the investigator(s) adhered to the CDC-NIH Guide for Biosafety in Microbiological and Biomedical Laboratories.Investigator Signature
ANIMAL USE SEPTEMBER 20,1997 THROUGH SEPTEMBER 19,1998
DAMD17-93-V-3013The experimental animals used during this period for the project, Neural Responses to Injury: Prevention, Protection, and Repair, Subproject: Neurochemical Protection of the Brain, Neural Plasticity and Repair, are as follows:
SpeciesNumber Allowed Number Used LSUIACUC# The development of chronic epilepsy is a very serious complication of head injury, neurodegenerative diseases, brain tumors, and exposure to neurotoxic agents. Head injury is often associated with loss of short-term memory, indicating trauma to t...